Inhibitor development in patients with type 3 Von Willebrand disease, a comprehensive study on 99 Iranian patients-Reference-Cited by-同舟云学术

Inhibitor development in patients with type 3 Von Willebrand disease, a comprehensive study on 99 Iranian patients

Published:2021-02-06 Issue:4 Volume:27 Page:0520
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Jazebi Mohammad¹,Baghaipour Mohammad Reza¹,Bahoush Gholam Reza¹²,Ala Fereydoun¹,Dorgalaleh Akbar³^ORCID,Moazezi Nekoei Asl Seyedeh Somayeh¹,Bahraini Mehran³,Baghaipour Nazanin¹,Tabibian Shadi³⁴^ORCID

Affiliation:

1. Iranian Comprehensive Hemophilia Care Center Tehran Iran

2. Department of Pediatrics Aliasghar Children’s HospitalSchool of Medicine, Iran University of Medical Science Tehran Iran

3. Department of Hematology and Blood Transfusion School of Allied Medicine Iran University of Medical Sciences Tehran Iran

4. Iranian Comprehensive Hemophilia Care Center, Blood and Viral Diseases Research Center Tehran Iran

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14266

Reference9 articles.

1. von Willebrand Disease: Differential Diagnosis and Diagnostic Approach to Specific Subtypes

2. Intracranial hemorrhage in congenital bleeding disorders

3. von Willebrand Disease

4. Von Willebrand disease in Iran: diagnosis and management;Dorgalaleh A;Ann Blood,2018

5. Type 3 VWD and an inhibitor to VWF: Challenges in diagnosis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare Occurrence of Inhibitors in Von Willebrand Disease: A Case Report;Frontiers in Medicine;2022-01-11